Belpointe Asset Management’s Chemours CC Stock Holding History

Belpointe Asset Management’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-515	Closed	-$15.4K	–	1012
2023 Q1	$15.4K	Sell	515 -213	-29%	-$7.02K	﹤0.01%	2459
2022 Q4	$22.3K	Buy	+728	New	+$21.8K	﹤0.01%	2107
2022 Q1	–	Sell	-8,795	Closed	-$295K	–	1232
2021 Q4	$295K	Buy	8,795 +666	+8%	+$20.7K	0.02%	719
2021 Q3	$236K	Buy	+8,129	New	+$263K	0.02%	790

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Belpointe Asset Management's CC Position: Q2 2023 in Review

Belpointe Asset Management sold out of Chemours (CC) in Q2 2023, closing a stake of 515 shares — an estimated $15.4K sold.

Belpointe Asset Management first reported a position in CC in Q3 2021 and held it in 4 quarters. The position peaked at $295K in Q4 2021. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

Belpointe Asset Management reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
Belpointe Asset Management sold 515 Chemours shares in Q2 2023, an estimated $15.4K.
Belpointe Asset Management first reported a position in Chemours in Q3 2021 and held it in 4 quarters.
Belpointe Asset Management's Chemours position peaked at $295K in Q4 2021.
476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.